1,2-Dichloroethane → N-[4-(pyrrolidin-1-ylimino)phenyl]-2-(2-bromophenyl)-2-(4-chlorophenylamino-carbonylamino)-acetamide
反応式
CN1CCN=C1C1[CH:12]=[CH:11][C:10]([NH:13][C:14](=[O:34])[CH:15]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=2[Br:33])[NH:16][C:17]([NH:19][C:20]2[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][CH:21]=2)=[O:18])=[CH:9]C=1.[N:35]1([N:40]=[C:41]2C=CC(N)=C[CH2:42]2)[CH2:39][CH2:38][CH2:37][CH2:36]1.C(Cl)CCl>CN(C=O)C.O>[N:35]1([N:40]=[C:41]2[CH:12]=[CH:11][C:10]([NH:13][C:14](=[O:34])[CH:15]([C:27]3[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=3[Br:33])[NH:16][C:17]([NH:19][C:20]3[CH:21]=[CH:22][C:23]([Cl:26])=[CH:24][CH:25]=3)=[O:18])=[CH:9][CH2:42]2)[CH2:39][CH2:38][CH2:37][CH2:36]1参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of 2-(2-bromophenyl)-2-(4-chlorophenylaminocarbonylamino)-acetic acid (from EXAMPLE 77, 60 mg, 0.16 mmol) and 4-(pyrrolidin-1-ylimino)phenylamine (60 mg, 0.31 mmol) in DMF (4 mL) and H2O (1 mL), EDC (120 mg, 0.62 mmol) was added. After being stirred at room temperature for 2 h, the mixture was concentrated in vacuo. The residue was purified by HPLC to give the titled compound as a powder (70 mg). MS 554.2 and 556.2 (M+H, Cl+Br pattern).
後処理
- concentrationthe mixture was concentrated in vacuo
- customThe residue was purified by HPLC
出典と根拠
- ORDレコード
- ord-7dc1c061c8b74dc188afca3b350e3ab4
- 出典データセット
- uspto-grants-2010_03
- 特許番号
- US07678913B2
反応ノート
読み込み中…